Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...

Rosino Sanchez A, Garcia Torralba E, Girela Baena E, Macias Cerrolaza JA, Tudela Pallares J, Zafra Poves M, Barcelo Bayonas I, Munoz Guillermo V, Fernandez Aparicio T. Early diagnosis of prostate cancer in healthy men with germline mutations in DNA Damage Response (DDR) pathways: A literature review and proposal for a screening strategy. Actas Urol Esp (Engl Ed). 2025 Apr;49(3):501686. doi: 10.1016/j.acuroe.2025.501686. Epub 2025 Feb 11. English, Spanish. PubMed PMID: 39947293.

AÑO: 2025

39947293

Jimenez-Vicente C, Esteve J, Baile-Gonzalez M, Perez-Lopez E, Martin Calvo C, Aparicio C, Oiartzabal Ormategi I, Esquirol A, Pena-Munoz F, Fernandez-Luis S, Heras Fernando I, Gonzalez-Rodriguez AP, Lopez-Garcia A, Lopez-Lorenzo JL, Torrado T, Saez Marin AJ, Acosta Fleytas C, Garcia L, Villar S, Filaferro S, Balsalobre P, Pascual Cascon MJ, Salas MQ. Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC). Blood Cancer J. 2025 Mar 21;15(1):42. doi: 10.1038/s41408-025-01223-x. PubMed PMID: 40118819; PubMed Central PMCID: PMC11928450.

AÑO: 2025; IF: 11.6

40118819

Sanchez-Fuentes A, Perez-Botero J, Bastida JM, Rivera J. Diagnosis of Inherited Platelet Disorders: Clinical Evaluation and Functional and Molecular Assays. Biomolecules. 2025 Jun 10;15(6):846. doi: 10.3390/biom15060846. PubMed PMID: 40563486; PubMed Central PMCID: PMC12191158.

AÑO: 2025; IF: 4.8

40563486

Lasa M, Notarfranchi L, Agullo C, Gonzalez C, Castro S, Perez JJ, Burgos L, Guerrero C, Calasanz MJ, Flores-Montero J, Oriol A, Bargay J, Rios R, Cabanas V, Cabrera C, Martinez-Martinez R, Encinas C, De Arriba F, Hernandez MT, Palomera L, Orfao A, Martinez-Lopez J, Mateos MV, San-Miguel J, Lahuerta JJ, Rosinol L, Blade J, Cedena MT, Puig N, Paiva B; PETHEMA/GEM Cooperative Group. Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma. J Clin Oncol. 2025 Jan 10;43(2):125-132. doi: 10.1200/JCO.24.00635. Epub 2024 Oct 1. PubMed PMID: 39353166.

AÑO: 2025; IF: 41.9

39353166

Muniz-Castrillo M, Blaya Boluda N, Garcia-Torralba E, Jimenez-Fonseca P, Gonzalez Del Rey C, Balbin M, Luengo-Gil G, Ayala de la Pena F, Esteban Gonzalez E, Carmona-Bayonas A. Dysfunctional mismatch repair in patients with early triple-negative breast cancer. Clin Transl Oncol. 2025 May 4. doi: 10.1007/s12094-025-03933-x. Online ahead of print. PubMed PMID: 40319412.

AÑO: 2025; IF: 2.5

40319412

Siguiente >

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Instituto de Investigación Sanitaria Acreditado

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL